FDA calls out 'particularly concerning' claims on HCP site for Taiho's Lytgobi
In an untitled letter issued last Friday and made public this week, the FDA took aim at clinical data included on a doctor-facing webpage for Taiho Oncology’s Lytgobi.

Mar 28, 2025 0
Mar 8, 2025 0
Mar 28, 2025 0
Mar 27, 2025 0
Mar 28, 2025 0
Mar 28, 2025 0
Mar 27, 2025 0
Mar 27, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 29, 2025 0
Mar 28, 2025 0
Mar 28, 2025 0
Mar 28, 2025 0
Mar 28, 2025 0
Mar 25, 2025 0
Mar 25, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 9, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.